Back to News
Market Impact: 0.35

BMO cuts RPM International stock price target to $148 on execution

RPM
Corporate EarningsCorporate Guidance & OutlookAnalyst EstimatesAnalyst InsightsCompany FundamentalsCommodities & Raw Materials
BMO cuts RPM International stock price target to $148 on execution

BMO Capital trimmed RPM International’s price target to $148 from $149 but kept an Outperform rating, citing continued growth, accretive M&A, and disciplined cost control. The company posted 5.68% trailing 12-month revenue growth to $7.71 billion, while fiscal Q3 2026 EPS of $0.57 beat estimates of $0.35 on revenue of $1.61 billion versus $1.55 billion expected. Analysts noted 8 upward earnings revisions and said RPM remains well positioned despite soft end-markets and raw material cost pressure.

Analysis

RPM is behaving like a quality compounder re-rating on execution, not a cyclical beta name. The market is starting to price in a margin-resilience story: if management keeps taking cost out while preserving pricing, the next leg of earnings could come from spread expansion rather than volume, which is usually worth a higher multiple in a slow-growth tape. The fact that estimate revisions are turning up matters more than the headline beat because it reduces the odds of a post-print giveback and supports a higher floor into the next few quarters. The underappreciated second-order effect is that RPM’s relative strength can force a read-across into the rest of the coatings and building-products universe. If RPM can defend margin with modest organic growth, weaker peers with less pricing power will likely see harsher multiple compression as investors separate "self-help" winners from purely cyclical names. That makes this less of a sector-wide bullish signal and more of a stock-picking catalyst: the best operators should keep outperforming, while balance-sheet-heavy or commodity-levered competitors lag if raw materials re-accelerate. The main risk is that this is a late-cycle quality bid and the market may already be paying for some of the good news after the recent run. Over the next 1-3 months, any reversal in input costs or evidence that pricing is slipping would quickly cap upside because the thesis depends on continued margin discipline, not just revenue growth. Over 12 months, the bigger risk is that M&A-driven EPS support is less repeatable than the market assumes, which would leave the stock exposed if organic growth remains only mid-single digits.